Beyond the Tech Giants: 35 Non-Tech AI Opportunities

8. IQVIA Holdings Inc. (NYSE:IQV)

Number of Hedge Fund Holders: 59

IQVIA Holdings Inc. (NYSE:IQV) engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. The uses AI extensively in various areas of healthcare and pharmaceutical services. Their AI technologies are applied to enhance drug discovery, development, and patient care, helping accelerate clinical trials and improve decision-making for treatments. Some key areas where AI plays a role include drug discovery and clinical trials, real-world data analysis, and talent acquisition. In the second quarter, the firm beat market expectations on earnings per share and revenue.

IQVIA Holdings Inc. (NYSE:IQV) is closely followed on Wall Street. RBC Capital recently initiated coverage of the stock with an Outperform rating and $275 price target. In an investor note, the advisory noted that the company is the largest global contract research organization, helping its biopharma clients bring drugs to market more quickly by leveraging its proprietary data, software and globally-scaled services. Analysts at the advisory added that fading headwinds were setting the stage for a meaningful earnings reacceleration, which should also help re-rate Iqvia’s valuation back toward its historical average.